Even though the clinical relevance of your aforementioned cardiovascular danger factor alterations by tirzepatide will be assessed from the planned cardiovascular outcome research SURPASS-CVOT ( "type":"medical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Examination indica